- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.11. | SANUWAVE targets $13M-$14M Q4 revenue while leveraging post-CMS rule clarity | 2 | Seeking Alpha | ||
| 07.11. | SANUWAVE Health GAAP EPS of $0.46 beats by $0.14, revenue of $11.5M beats by $0.07M | 1 | Seeking Alpha | ||
| 07.11. | SANUWAVE Health, Inc.: Sanuwave Announces Q3 FY2025 Financial Results | 95 | GlobeNewswire (Europe) | Q3 2025 revenues were $11.5 million, up 22% from $9.4 million in Q3 2024. This represents the highest quarterly revenues in Company history. Q3 2025 gross margin was 77.9%, versus 75.5% in Q3 2024.... ► Artikel lesen | |
| 07.11. | SANUWAVE Health, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 06.11. | SANUWAVE Health, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 05.11. | An Overview of SANUWAVE Health's Earnings | 1 | Benzinga.com | ||
| 03.11. | SANUWAVE Health, Inc.: CMS Publishes Final Rule for Calendar Year 2026 Physician Fee Schedule for UltraMIST Procedure (CPT code 97610) | 4 | GlobeNewswire (USA) | ||
| 30.10. | SANUWAVE Health, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| SANUWAVE HEALTH Aktie jetzt für 0€ handeln | |||||
| 06.10. | Sanuwave reports record quarterly revenue of $11.4-11.6 million | 1 | Investing.com | ||
| 06.10. | Sanuwave Health expects Q3 revenue between $11.4M and $11.6M | 1 | Seeking Alpha | ||
| 06.10. | SANUWAVE Health, Inc.: Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025) | 107 | GlobeNewswire (Europe) | Sanuwave announces preliminary revenues of $11.4 million to $11.6 million for the third quarter ended September 30, 2025. This represents the highest quarterly revenues in Company history. Q3 2025... ► Artikel lesen | |
| 01.10. | Sanuwave Health baut Führungsebene um: Daniel Coyle wird neuer Chief Operating Officer | 1 | Investing.com Deutsch | ||
| 30.09. | Sanuwave Health is a buy, this analyst says | 1 | Cantech Letter | ||
| 26.09. | SANUWAVE Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 26.09. | Sanuwave refinances debt with new credit facility | 1 | Seeking Alpha | ||
| 26.09. | Sanuwave Health refinances $27.5 million debt with J.P. Morgan facility | 3 | Investing.com | ||
| 26.09. | SANUWAVE Health, Inc.: Sanuwave Announces Strategic Debt Refinancing with New Credit Facility | 746 | GlobeNewswire (Europe) | Credit facility from J.P. Morgan consists of a four-year term loan of $23 million and a two-year $5 million revolving credit facility backed by accounts receivable Both the term loan and revolver... ► Artikel lesen | |
| 03.09. | SANUWAVE Health stock initiated with Outperform rating at Northland | 1 | Investing.com | ||
| 22.08. | SANUWAVE Health, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 22.08. | Sanuwave Health rises after $5M payment related to patent sale | 1 | Seeking Alpha |
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 42,530 | +0,83 % | DAX bald auf 6-Monats-Tief - BMW, RTL, SAP, Scout, SFC Energy und Siemens Healthineers im ... | Die Sorge über eine weniger lockere Geldpolitik der US-Notenbank hat zum Wochenstart die internationalen Aktienmärkte - darunter auch den DAX - auf Talfahrt geschickt. Die Tendenz setzt sich zum Handelsstart... ► Artikel lesen | |
| FRESENIUS | 47,660 | +0,97 % | Fresenius SE wackelt - dieser Boden sollte halten | Die Fresenius SE-Aktie steht kurz vor einer wichtigen Unterstützung. Hält der Bereich, oder droht ein Rückfall in tiefere Kursregionen Den vollständigen Artikel lesen ... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,670 | +0,65 % | FMC, Lanxess, Norma, Redcare Pharmacy, Suss MicroTec, TKMS - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,105 | +8,43 % | Alignment Healthcare stock rating upgraded by JPMorgan to Overweight | ||
| CARL ZEISS MEDITEC | 46,100 | +2,44 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hatCarl Zeiss Meditec auf "Overweight" mit einem Kursziel von 52 Euro belassen. Die Aktienkurse der europäischen Medizintechnik-Unternehmen... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 32,260 | +7,50 % | Piper Sandler Reiterates a Buy on PROCEPT BioRobotics Corporation (PRCT) | ||
| BRIGHTSPRING HEALTH SERVICES | 36,200 | +2,87 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| GENEDX | 167,46 | +3,91 % | GeneDx auf der Jefferies London Konferenz: Strategische Expansion in der Pädiatrie | ||
| GERRESHEIMER | 24,860 | +2,39 % | EQS-News: Gerresheimer AG: Science Based Targets Initiative bestätigt CO2e Reduktionsziele | EQS-News: Gerresheimer AG
/ Schlagwort(e): Nachhaltigkeit
Gerresheimer: Science Based Targets Initiative bestätigt CO2e Reduktionsziele
18.11.2025 / 10:02 CET/CEST
Für... ► Artikel lesen | |
| PROGYNY | 26,810 | +1,82 % | Progyny, Inc.: New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action | ||
| PACS GROUP | 32,000 | +6,70 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| NUTEX HEALTH | 120,05 | -12,42 % | Nutex Health, Inc.: Nutex Health Reports September 30, 2025 Third Quarter And Year-to-date Financial Results | Total revenue of $723.6 million for the first nine months of 2025 versus $222.3 million for the first nine months of 2024, an increase of 225.5%
Net... ► Artikel lesen | |
| BILLIONTOONE | 128,80 | +7,21 % | BillionToOne, Inc.: BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares | MENLO PARK, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced... ► Artikel lesen | |
| ADAPTHEALTH | 9,670 | -1,88 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| ONCOLOGY INSTITUTE | 3,175 | +4,44 % | The Oncology Institute GAAP EPS of -$0.14 misses by $0.03, revenue of $136.6M beats by $13.97M |
Das Unternehmen SANUWAVE HEALTH INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +3,80 % bei einem Aktienkurs von 34,920 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SANUWAVE HEALTH INC finden Sie auf Wallstreet Online.